Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Inside Epstein’s infamous ‘birthday book’: Clinton’s note, poolside...
Whole milk makes a comeback in new MAHA...
Hawley pushes legal action against Meta after whistleblowers...
As Trump’s bawdy birthday message to Jeffrey Epstein...
Elon Musk agrees with JD Vance on the...
Scalise hints GOP may push nationwide crime crackdown...
Harris admits Biden ‘got tired,’ denies ‘conspiracy’ to...
GOP senator compares Israel’s Hamas fight to US...
Trump calls for death penalty for suspect in...
Jury selection still underway in Ryan Routh trial,...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

previous post
5 Best-performing Canadian Nickel Stocks of 2024
next post
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

You may also like

Canadian Investment Regulatory Organization Trade Resumption – PRIZ

July 19, 2025

Top 5 Life Science ETFs in 2024

November 20, 2024

Charbone Hydrogene resout la perturbation temporaire du service...

January 10, 2025

CoTec Holdings Corp. Notes HyProMag USA Press Release...

September 5, 2025

Lupin Protein Health Benefits Presentation

March 24, 2025

Lode Gold Announces $1,000,000 Financing

February 16, 2025

Skyharbour Announces Closing of Private Placement for Gross...

December 21, 2024

Nuvau Launches Follow up Drilling to Bracemac Footwall...

August 12, 2025

Don Durrett: Gold, Silver Price Targets and 15...

February 8, 2025

Maverick Metals Secures US$19 Million to Fast Track...

April 9, 2025

Recent Posts

  • Inside Epstein’s infamous ‘birthday book’: Clinton’s note, poolside candids and bizarre animal pics
  • Whole milk makes a comeback in new MAHA children’s health strategy
  • Hawley pushes legal action against Meta after whistleblowers detail child abuse in VR
  • As Trump’s bawdy birthday message to Jeffrey Epstein appears, he still insists he never sent it
  • Elon Musk agrees with JD Vance on the ‘big lie the Democrats told about violent crime’

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (913)
    • Investing (2,932)
    • Politics (3,601)
    • Stock (4)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.